Supplementary Data from Rational Combination Therapy for Melanoma with Dinaciclib by Targeting BAK-Dependent Cell Death
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 1 shows that CDK2 and CDK9 are involved in BAK-dependent melanoma apoptosis induced by dinaciclib.Supplementary Figure 2 shows that BRAF inhibition suppresses melanoma through BAX. Supplementary Figure 3 shows combinational effects of dinaciclib with BAX-activating drugs.
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362482192
